Skip to content

Clinical trials

Phase 3 Carcinoma trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Phase: Phase 3 Country / region: Russia Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20091
20102
20171
20184
20194

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting5
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Merck Sharp & Dohme LLC2
Abbott1
Bayer1
Exelixis1
Novartis Pharmaceuticals1
Oncolytics Biotech1
Pfizer1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma14
Carcinoma, Non-Small-Cell Lung6
Neoplasm Metastasis3
Carcinoma, Hepatocellular2
Lung Neoplasms2
Neoplasms2
Neoplasms by Site2
Adenocarcinoma1
Carcinoma, Large Cell1
Carcinoma, Renal Cell1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.